Headshot of Todd Cooper

Todd Cooper

Seattle Children’s is embarking on a groundbreaking clinical trial that will potentially transform treatment methods for children with relapsed acute pediatric leukemia. The trial will test multiple targeted therapies simultaneously at up to 200 clinical sites worldwide, including Seattle Children’s.

“Our goal is to get everyone to the table and work together. We’ve come to realize that’s the only way to make further progress,” says Dr. Todd Cooper of Seattle Children’s, who will head the new clinical trial. Dr. Cooper is an oncologist and director of the Seattle Children’s High-Risk Leukemia Program. He will oversee the master screening trial where children with newly diagnosed and relapsed acute leukemia can choose to have their clinical and biologic information included in an international database. The database will serve many purposes, including helping to determine an individual child’s eligibility for a number of targeted clinical trials. The data will also be used to uncover new targets for therapy and serve as a rich source for groundbreaking discoveries.


Seattle Children’s research in other news:

  • NIH awards contract to advance tuberculosis immunology research: The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $30 million in first-year funding to Seattle Children’s and two other institutions to establish new centers for immunology research to accelerate progress in tuberculosis (TB) vaccine development. The principal investigator is Kevin Urdahl, MD, PhD.
  • New program will focus research on combating Zika virus: A new program delving into how viruses and bacteria attack the fetus, and how the body fights back, has been created at UW Medicine. The research program was made possible after two UW researchers recently received almost $19 million in NIH grants. The latest funding leverages a close collaboration with Lakshmi Rajagopal, PhD, a scientist at Seattle Children’s Research Institute and professor of pediatrics at UW School of Medicine.